FARRUKH KUREISHY: Open Payments
NPI 1619950060 · CLINTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,875 in 215 payments from 32 companies in 2025. Trend: 2023 $37,055 · 2024 $43,298 · 2025 $33,875
Speaker / faculty: $21,021Consulting: $5,800Food & beverage: $4,240Travel & lodging: $2,765Education: $49
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 35 | $23,988 |
| Teva Pharmaceuticals USA, Inc. | 7 | $6,803 |
| AstraZeneca Pharmaceuticals LP | 18 | $604 |
| Aimmune Therapeutics, Inc. | 9 | $290 |
| Novo Nordisk Inc | 21 | $286 |
| PFIZER INC. | 27 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $248 |
| Amgen Inc. | 15 | $151 |
| Novartis Pharmaceuticals Corporation | 15 | $143 |
| Axsome Therapeutics, Inc. | 5 | $112 |
Products named: INGREZZA, AUSTEDO XR, BREZTRI, ZENPEP, CAPLYTA, ELIQUIS, Ozempic, OTEZLA.
Industry payments across IL — which companies pay providers there.
